141 related articles for article (PubMed ID: 7697920)
41. Cooperative activation of TCRs by enterotoxin superantigens.
Niedergang F; Dautry-Varsat A; Alcover A
J Immunol; 1998 Dec; 161(11):6054-8. PubMed ID: 9834088
[TBL] [Abstract][Full Text] [Related]
42. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.
Soos JM; Hobeika AC; Butfiloski EJ; Schiffenbauer J; Johnson HM
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6082-6. PubMed ID: 7541140
[TBL] [Abstract][Full Text] [Related]
43. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation.
van der Fits L; Sandberg Y; Darzentas N; Zoutman WH; Tielemans D; Wolvers-Tettero IL; Vermeer MH; Langerak AW
Br J Dermatol; 2011 Jul; 165(1):78-84. PubMed ID: 21410672
[TBL] [Abstract][Full Text] [Related]
44. [Anomalies of the immune system in chronic inflammatory bowel diseases].
Jacquot S; Boumsell L; Bensussan A; Modigliani R
Gastroenterol Clin Biol; 1994; 18(11):945-53. PubMed ID: 7705582
[No Abstract] [Full Text] [Related]
45. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
D'Orazio JA; Stein-Streilein J
Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
[TBL] [Abstract][Full Text] [Related]
46. T cell receptor repertoire and mitotic responses of lamina propria T lymphocytes in inflammatory bowel disease.
Qiao L; Golling M; Autschbach F; Schürmann G; Meuer SC
Clin Exp Immunol; 1994 Aug; 97(2):303-8. PubMed ID: 8050181
[TBL] [Abstract][Full Text] [Related]
47. Directed evolution of T-cell receptors for binding superantigens.
Churchill HR; Kranz DM
Methods Mol Biol; 2003; 214():87-99. PubMed ID: 12489456
[No Abstract] [Full Text] [Related]
48. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products.
Gold DP; Surh CD; Sellins KS; Schroder K; Sprent J; Wilson DB
J Exp Med; 1994 Jan; 179(1):63-9. PubMed ID: 8270884
[TBL] [Abstract][Full Text] [Related]
49. Pathogenesis of inflammatory bowel disease.
Zeitz M
Digestion; 1997; 58 Suppl 1():59-61. PubMed ID: 9225095
[No Abstract] [Full Text] [Related]
50. Genes, bacteria, and T cells: ingredients for inflammatory bowel disease.
Shanahan F; O'Sullivan GC; Collins JK
Gastroenterology; 1998 Dec; 115(6):1595-6. PubMed ID: 9834293
[No Abstract] [Full Text] [Related]
51. Receptor-mediated lymphocyte apoptosis in health and disease.
Siegel R
J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S16. PubMed ID: 15805831
[No Abstract] [Full Text] [Related]
52. Control of adaptive immunity: from naïve to memory.
Farber DL
J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S17-9. PubMed ID: 15805832
[No Abstract] [Full Text] [Related]
53. Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease.
Murphy G
Agents Actions; 1993 Jan; 38(1-2):i-iii. PubMed ID: 8480529
[No Abstract] [Full Text] [Related]
54. Chronic sequelae of foodborne disease.
Lindsay JA
Emerg Infect Dis; 1997; 3(4):443-52. PubMed ID: 9366595
[TBL] [Abstract][Full Text] [Related]
55. The potential role of superantigens in inflammatory bowel disease.
Kay RA
Clin Exp Immunol; 1995 Apr; 100(1):4-6. PubMed ID: 7697920
[No Abstract] [Full Text] [Related]
56. Superantigens.
Rosen H
Int J Dermatol; 1997 Jan; 36(1):14-6. PubMed ID: 9071608
[No Abstract] [Full Text] [Related]
57. Potential role of superantigens in gastrointestinal disease.
James SP
Gastroenterology; 1993 Nov; 105(5):1569-71. PubMed ID: 8224666
[No Abstract] [Full Text] [Related]
58. Bacterial superantigens: provocateurs of gut dysfunction and inflammation?
McKay DM
Trends Immunol; 2001 Sep; 22(9):497-501. PubMed ID: 11525940
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory bowel disease: etiology and pathogenesis.
Fiocchi C
Gastroenterology; 1998 Jul; 115(1):182-205. PubMed ID: 9649475
[No Abstract] [Full Text] [Related]
60. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.
Bosè F; Raeli L; Garutti C; Frigerio E; Cozzi A; Crimi M; Caprioli F; Scavelli R; Altomare G; Geginat J; Abrignani S; Reali E
Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
